Identifying ecological factors that drive the evolution of innate versus adaptive immunity in bacteria
识别驱动细菌先天免疫和适应性免疫进化的生态因素
基本信息
- 批准号:NE/M018350/1
- 负责人:
- 金额:$ 67.02万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Fellowship
- 财政年份:2015
- 资助国家:英国
- 起止时间:2015 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
How are we going to deal with bacterial infections if pathogens are resistant to antibiotics? And how do we protect bacteria that are useful for industrial production of cheese and yoghurt against their parasites (bacteriophages, the viruses of bacteria)? These are questions of great societal and economic importance that need to be addressed in the near future. The answer to the first question may well lie in the application of parasites that cause the economic problems in industry that is referred to in the second question. Like all organisms bacteria face infectious diseases caused by parasites (bacteriophages) that abuse host resources for their own benefit. These bacteriophages sometimes cause severe problems in food industry, but can perhaps also be applied to fight bacterial infections in humans, or bacterial infections of crops in agriculture. However, bacteria evolved several mechanisms to acquire immunity against bacteriophages. Understanding how bacteriophage immunity evolves in bacteria is one of the key objectives of my research. I am particularly interested in the evolution of two distinct immune mechanisms: bacterial innate and adaptive immunity. I will test how environmental variables impact on the evolution of either immunity mechanism. This will hopefully lead us to conditions where both immune systems of the bacterial host are ineffective, which will aid the use of bacteriophages to combat bacterial infections. On the other hand, my research will likely also identify conditions where the immune system of bacteria is highly effective, which can then be used in food industry to avoid that bacteria that produce our food (e.g. yoghurt) become infected with bacteriophage, which results in severe economic losses. Hence, my research will reveal how, when and why ecological factors drive the evolution of bacterial immunity against bacteriophages. This information is only one step away from applications in industry, where bacteria need to be protected from bacteriophages. Bioreactors could be designed in such a way that bacterial immunity levels are optimal, which would strongly reduce the frequency of bacteriophage infections and the concomitant economic losses. For the purpose of treating patients that are infected with antibiotic resistant bacterial pathogens, phages can be used as an alternative treatment (phage therapy). In this context, my research will provide clues what the optimal treatment method may be in order to avoid or at least reduce the evolution of bacterial immunity against the bacteriophages. Although phage therapy is not yet used on patients, many believe this to be the medicine of the future and a promising alternative for antibiotics. Nevertheless, phage therapy is already being applied in agriculture, to protect crops from bacterial infections, and in food preservations, for example to avoid contamination of food with pathogenic bacteria. Hence, the knowledge gained from my research can be directly implemented to optimize the procedures of applying bacteriophages to combat unwanted bacteria. Apart from these important applications, my research will also provide fundamental insights into the evolution of immunity mechanisms and how their evolution is affected by ecological factors. This may provide general insights that are also applicable to other systems. For example, it will help us to understand how immune systems evolve in nature and what their importance is in controlling diseases and how they influence the evolution and spread of parasites.
如果病原体对抗生素有抗药性,我们将如何处理细菌感染?我们如何保护用于工业生产奶酪和酸奶的细菌免受寄生虫(噬菌体,细菌病毒)的侵害?这些都是具有重大社会和经济意义的问题,需要在不久的将来加以解决。第一个问题的答案很可能在于寄生虫的应用,这种寄生虫会导致第二个问题中提到的工业经济问题。与所有生物一样,细菌面临着由寄生虫(噬菌体)引起的传染病,这些寄生虫为了自身的利益而滥用宿主资源。这些噬菌体有时会在食品工业中引起严重的问题,但也可能用于对抗人类的细菌感染或农业作物的细菌感染。然而,细菌进化出几种机制来获得针对噬菌体的免疫力。了解噬菌体免疫如何在细菌中进化是我研究的关键目标之一。我对两种不同免疫机制的进化特别感兴趣:细菌先天免疫和适应性免疫。我将测试环境变量如何影响免疫机制的进化。这将有希望引导我们到细菌宿主的两个免疫系统都无效的情况下,这将有助于使用噬菌体来对抗细菌感染。另一方面,我的研究也可能确定细菌免疫系统高度有效的条件,然后可以用于食品工业,以避免生产我们食物(例如酸奶)的细菌感染噬菌体,从而导致严重的经济损失。因此,我的研究将揭示生态因素如何,何时以及为什么驱动细菌对噬菌体的免疫进化。这些信息距离工业应用只有一步之遥,在工业中需要保护细菌免受噬菌体的侵害。生物反应器的设计可以使细菌免疫水平达到最佳,这将大大降低噬菌体感染的频率和随之而来的经济损失。为了治疗感染抗生素耐药细菌病原体的患者,噬菌体可用作替代治疗(噬菌体疗法)。在这种情况下,我的研究将提供最佳治疗方法的线索,以避免或至少减少细菌对噬菌体的免疫力的进化。虽然噬菌体疗法尚未用于患者,但许多人认为这是未来的药物,是抗生素的一种有前途的替代品。尽管如此,噬菌体疗法已经应用于农业,以保护作物免受细菌感染,并用于食品消毒,例如避免食品被病原菌污染。因此,从我的研究中获得的知识可以直接用于优化应用噬菌体对抗有害细菌的程序。除了这些重要的应用外,我的研究还将为免疫机制的进化以及它们的进化如何受到生态因素的影响提供基本见解。这可以提供也适用于其他系统的一般见解。例如,它将帮助我们了解免疫系统在自然界中如何进化、它们在控制疾病方面的重要性以及它们如何影响寄生虫的进化和传播。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulation of prophage induction and lysogenization by phage communication systems.
- DOI:10.1016/j.cub.2021.08.073
- 发表时间:2021-11-22
- 期刊:
- 影响因子:0
- 作者:Bruce JB;Lion S;Buckling A;Westra ER;Gandon S
- 通讯作者:Gandon S
Bacterial biodiversity drives the evolution of CRISPR-based phage resistance in Pseudomonas aeruginosa
细菌多样性推动铜绿假单胞菌基于 CRISPR 的噬菌体抗性进化
- DOI:10.1101/586115
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Alseth E
- 通讯作者:Alseth E
Evolutionary emergence of infectious diseases in heterogeneous host populations.
- DOI:10.1371/journal.pbio.2006738
- 发表时间:2018-09
- 期刊:
- 影响因子:9.8
- 作者:Chabas H;Lion S;Nicot A;Meaden S;van Houte S;Moineau S;Wahl LM;Westra ER;Gandon S
- 通讯作者:Gandon S
The effect of Quorum sensing inhibitors on the evolution of CRISPR-based phage immunity in Pseudomonas aeruginosa.
- DOI:10.1038/s41396-021-00946-6
- 发表时间:2021-08
- 期刊:
- 影响因子:0
- 作者:Broniewski JM;Chisnall MAW;Høyland-Kroghsbo NM;Buckling A;Westra ER
- 通讯作者:Westra ER
Individual bacteria in structured environments rely on phenotypic resistance to phage.
- DOI:10.1371/journal.pbio.3001406
- 发表时间:2021-10
- 期刊:
- 影响因子:9.8
- 作者:Attrill EL;Claydon R;Łapińska U;Recker M;Meaden S;Brown AT;Westra ER;Harding SV;Pagliara S
- 通讯作者:Pagliara S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edze Rients Westra其他文献
Edze Rients Westra的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edze Rients Westra', 18)}}的其他基金
22-BBSRC/NSF-BIO: Community-dependent CRISPR-cas evolution and robust community function
22-BBSRC/NSF-BIO:群落依赖性 CRISPR-cas 进化和强大的群落功能
- 批准号:
BB/Y008774/1 - 财政年份:2024
- 资助金额:
$ 67.02万 - 项目类别:
Research Grant
Multi-layered bacterial genome defences: linking molecular mechanisms to bacteria-MGE conflicts in single cells, populations, and communities.
多层细菌基因组防御:将分子机制与单细胞、群体和群落中的细菌-MGE 冲突联系起来。
- 批准号:
BB/X003051/1 - 财政年份:2023
- 资助金额:
$ 67.02万 - 项目类别:
Research Grant
COMMUNICATE: Understanding the evolution and ecology of viral communication
沟通:了解病毒式传播的进化和生态
- 批准号:
EP/X030377/1 - 财政年份:2023
- 资助金额:
$ 67.02万 - 项目类别:
Research Grant
The impact of spatial structure of CRISPR-phage coevolution
CRISPR-噬菌体协同进化空间结构的影响
- 批准号:
NE/S001921/1 - 财政年份:2019
- 资助金额:
$ 67.02万 - 项目类别:
Research Grant
Identifying factors that drive CRISPR-Cas-dependent phage resistance in bacteria
识别细菌中 CRISPR-Cas 依赖性噬菌体抗性的驱动因素
- 批准号:
BB/N017412/1 - 财政年份:2017
- 资助金额:
$ 67.02万 - 项目类别:
Research Grant
相似国自然基金
黄土高原半城镇化农民非农生计可持续性及农地流转和生态效应
- 批准号:41171449
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
脆弱生态约束下岩溶山区乡村可持续发展的导向模式研究
- 批准号:40561006
- 批准年份:2005
- 资助金额:23.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Identifying Factors Influencing Alcohol Use after Bariatric Surgery: An Ecological Momentary Assessment
确定减肥手术后影响饮酒的因素:生态瞬时评估
- 批准号:
10439039 - 财政年份:2023
- 资助金额:
$ 67.02万 - 项目类别:
Identifying barriers and facilitators of harm reduction among adult dual users of e-cigarettes and cigarettes
确定电子烟和香烟成人双重使用者减少伤害的障碍和促进因素
- 批准号:
10590814 - 财政年份:2023
- 资助金额:
$ 67.02万 - 项目类别:
Identifying Transdiagnostic Intervention Targets for PTSD-SUD Comorbidity in a Vulnerable Population: A Mixed-Method Study
确定弱势群体 PTSD-SUD 合并症的跨诊断干预目标:混合方法研究
- 批准号:
10726507 - 财政年份:2023
- 资助金额:
$ 67.02万 - 项目类别:
A translational approach for identifying factors and mechanisms underlying pathological anxiety in preadolescent girls
识别青春期前女孩病理性焦虑的因素和机制的转化方法
- 批准号:
10637744 - 财政年份:2023
- 资助金额:
$ 67.02万 - 项目类别:
Identifying Treatment Effects, Mechanisms, and Moderators in Youth Cannabis Use Treatment Using Ecological Momentary Assessment
使用生态瞬时评估确定青少年大麻使用治疗的治疗效果、机制和调节因素
- 批准号:
10687149 - 财政年份:2021
- 资助金额:
$ 67.02万 - 项目类别:
Identifying Treatment Effects, Mechanisms, and Moderators in Youth Cannabis Use Treatment Using Ecological Momentary Assessment
使用生态瞬时评估确定青少年大麻使用治疗的治疗效果、机制和调节因素
- 批准号:
10312285 - 财政年份:2021
- 资助金额:
$ 67.02万 - 项目类别:
Identifying Treatment Effects, Mechanisms, and Moderators in Youth Cannabis Use Treatment Using Ecological Momentary Assessment
使用生态瞬时评估确定青少年大麻使用治疗的治疗效果、机制和调节因素
- 批准号:
10487431 - 财政年份:2021
- 资助金额:
$ 67.02万 - 项目类别:
Identifying Modifiable Risk and Protective Processes at the Day-Level that Predict HIV Care Outcomes Among Women Exposed to Partner Violence
识别日间可改变的风险和保护流程,预测遭受伴侣暴力的妇女的艾滋病毒护理结果
- 批准号:
10524760 - 财政年份:2020
- 资助金额:
$ 67.02万 - 项目类别:
Identifying Modifiable Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes
确定儿童 1 型糖尿病神经认知并发症的可改变风险和保护因素
- 批准号:
9913817 - 财政年份:2019
- 资助金额:
$ 67.02万 - 项目类别:
Identifying Modifiable Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes
确定儿童 1 型糖尿病神经认知并发症的可改变风险和保护因素
- 批准号:
10021646 - 财政年份:2019
- 资助金额:
$ 67.02万 - 项目类别: